Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...
Artificial intelligence (AI) isn't the only industry with explosive growth potential.
Zacks Investment Research on MSN
Should you invest in the Invesco Biotechnology & Genome ETF (PBE)?
The Invesco Biotechnology & Genome ETF (PBE) was launched on June 23, 2005, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the ...
From Adelaide to San Francisco, the biotechnology landscape is shifting – and, in some cases, straining under the weight of ...
Biotech stocks are emerging from a four-year slump. The SPDR S&P Biotech exchange-traded fund XBI, a proxy for the sector, is up 25% so far this year through Oct. 31, beating the S&P 500 SPX by 9 ...
The business may not be as strong as its performance this year suggests.
China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...
The value of Chinese biotechnology companies has increased more than 100-fold over the past decade.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results